LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Home・Aandelen Lijst・Adverum Biotechnologies Inc
Search

Adverum Biotechnologies Inc

Gesloten

SectorGezondheidszorg

0

Buy

Prijsupdate 1 jan 1970, 00:00 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+11.93% upside

Nieuwssentiment

By Acuity

50%

50%

159 / 347 Rangschikking in Healthcare

Adverum Biotechnologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 okt 2025, 13:04 UTC

Acquisities, Fusies, Overnames

Eli Lilly Agrees to Acquire Adverum Biotechnologies

DJ

Lezen

9 dec 2025, 13:32 UTC

Acquisities, Fusies, Overnames

Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY

DJ

Lezen

9 dec 2025, 13:32 UTC

Acquisities, Fusies, Overnames

Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs

DJ

Lezen

9 dec 2025, 13:29 UTC

Acquisities, Fusies, Overnames

Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition

DJ

Lezen

24 okt 2025, 12:34 UTC

Acquisities, Fusies, Overnames

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

DJ

Lezen

24 okt 2025, 12:34 UTC

Acquisities, Fusies, Overnames

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

DJ

Lezen

24 okt 2025, 12:33 UTC

Acquisities, Fusies, Overnames

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

DJ

Lezen

24 okt 2025, 12:30 UTC

Acquisities, Fusies, Overnames

Lilly To Acquire Adverum Biotechnologies >LLY ADVM

DJ

Lezen

Peer Vergelijking

Prijswijziging

Adverum Biotechnologies Inc Prognose

Koersdoel

By TipRanks

11.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.88 USD  11.93%

Hoogste 5.5 USD

Laagste 4 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Adverum Biotechnologies Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Adverum Biotechnologies Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

159 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

947.62

↓-2.8%

JNJ

Johnson and Johnson

221.12

↓-0.62%

ABBV

AbbVie Inc

201.14

↓-0.71%

UNH

UnitedHealth Group Inc

379.44

↑ +2.66%

AZN

AstraZeneca PLC

182.32

↑ +0.05%
help-icon Live chat